NYSEArca - Delayed Quote USD

Amplify Weight Loss Drug & Treatment ETF (THNR)

27.05 +0.13 (+0.47%)
At close: September 9 at 1:44 PM EDT
28.00 +0.89 (+3.28%)
After hours: September 9 at 4:06 PM EDT
Loading Chart for THNR
DELL
  • Previous Close 26.93
  • Open 27.06
  • Bid 13.54 x 900
  • Ask 27.08 x 800
  • Day's Range 27.05 - 27.21
  • 52 Week Range 24.92 - 28.19
  • Volume 561
  • Avg. Volume 5,257
  • Net Assets 3.94M
  • NAV 27.02
  • PE Ratio (TTM) --
  • Yield --
  • YTD Daily Total Return --
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.59%

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Amplify ETFs

Fund Family

Health

Fund Category

3.94M

Net Assets

2024-05-20

Inception Date

Performance Overview: THNR

View More

Trailing returns as of 9/6/2024. Category is Health.

YTD Return

THNR
0.00%
Category
12.21%
?

1-Year Return

THNR
0.00%
Category
16.25%
?

3-Year Return

THNR
0.00%
Category
1.82%
?

People Also Watch

Holdings: THNR

View More

Top 10 Holdings (72.06% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 14.78%
NVO
Novo Nordisk A/S 12.82%
AZN
AstraZeneca PLC 7.38%
4519.T
Chugai Pharmaceutical Co., Ltd. 6.56%
ROG.SW
Roche Holding AG 5.60%
4901.T
FUJIFILM Holdings Corporation 5.31%
AMGN
Amgen Inc. 5.12%
TMO
Thermo Fisher Scientific Inc. 4.91%
MRK.DE
Merck KGaA 4.79%
PFE
Pfizer Inc. 4.78%

Sector Weightings

Recent News: THNR

View More

Research Reports: THNR

View More

Related Tickers